Acute Respiratory Distress Syndrome clinical trials at UC Davis
2 research studies open to eligible people
Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome
open to eligible people ages 18 years and up
This is a Phase 2b, randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of a single dose of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) infusion in patients with Acute Respiratory Distress Syndrome (ARDS). This study is the extension of the Phase 1 pilot study (NCT01775774) and Phase 2a study (NCT02097641).
Sacramento, California and other locations
Sigh Ventilation to Increase Ventilator-Free Days in Victims of Trauma at Risk for Acute Respiratory Distress Syndrome
“The study team wants to know if adding a sigh-type of breath to a ventilator reduces chances of developing more serious lung problems.”
open to eligible people ages 18-89
A randomized, concurrent controlled trial to assess if adding sigh breaths to usual invasive mechanical ventilation of victims of trauma who are at risk of developing ARDS will decrease the number of days they require invasive mechanical ventilation.
Sacramento, California and other locations